Hepatitis B virus and hepatitis D virus entry, species specificity, and tissue tropism

Cold Spring Harbor Perspectives in Medicine

Volumn 5, Issue 8, 2015, Pages 1-10

  Watashi, Koichi ^a   Wakita, Takaji ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID CONJUGATE; NEUTRALIZING ANTIBODY; SODIUM BILE ACID COTRANSPORTER; TAUROCHOLIC ACID; TAURODEOXYCHOLIC ACID; VIRUS ENVELOPE PROTEIN; VIRUS RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL SURFACE; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DELTA AGENT HEPATITIS; FEMALE; HEPADNAVIRIDAE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HOST CELL; HUMAN; HUMAN CELL; LIVER CELL; NONHUMAN; PROTEIN DOMAIN; PROTEIN PROCESSING; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS; SPECIES DIFFERENCE; TISSUE TROPISM; TROPISM; VIRAL TROPISM; VIRION; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS PARTICLE; MALE; METABOLISM; PATHOGENICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; VIROLOGY;

HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS;

FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; MALE; RECEPTORS, VIRUS; SPECIES SPECIFICITY; TAUROCHOLIC ACID; TROPISM; VIRAL ENVELOPE PROTEINS; VIRION; VIRUS INTERNALIZATION;

EID: 84938687698     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a021378     Document Type: Article

References (68)

1. Abou-Jaoude G, Sureau C. 2007. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange. J Virol 81: 13057–13066.
2. Araki K, Miyazaki J, Hino O, Tomita N, Chisaka O, Matsubara K, Yamamura K. 1989. Expression and replication of hepatitis B virus genome in transgenic mice. Proc Natl Acad Sci 86: 207–211.
3. Barrera A, Guerra B, Notvall L, Lanford RE. 2005. Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition. J Virol 79: 9786–9798.
4. Bremer CM, Sominskaya I, Skrastina D, Pumpens P, El Wahed AA, Beutling U, Frank R, Fritz HJ, Hunsmann G, Gerlich WH, et al. 2011. N-terminal myristoylationdependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus. J Hepatol 55: 29–37.
5. Bruss V, Hagelstein J, Gerhardt E, Galle PR. 1996. Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity. Virology 218: 396–399.
6. Cooper A, Shaul Y. 2006. Clathrin-mediated endocytosis and lysosomal cleavage of hepatitis B virus capsid-like core particles. J Biol Chem 281: 16563–16569.
7. Dawson PA, Lan T, Rao A. 2009. Bile acid transporters. J Lipid Res 50: 2340–2357.
8. De Falco S, Ruvo M, Verdoliva A, Scarallo A, Raimondo D, Raucci A, Fassina G. 2001. N-terminal myristylation of HBV preS1 domain enhances receptor recognition. J Pept Res 57: 390–400.
9. Engelke M, Mills K, Seitz S, Simon P, Gripon P, Schnolzer M, Urban S. 2006. Characterization of a hepatitis B and hepatitis delta virus receptor binding site. Hepatology 43: 750–760.
10. Gao Z, Li M, He W, Li W. 2013. Hepatitis B virus may enter HepG2 cells complemented with human NTCP via macropinocytosis. In 2013 International Meeting on Molecular Biology of Hepatitis B Viruses, p. O-2. Shanghai, China.
11. Glebe D, Urban S, Knoop EV, Cag N, Krass P, Grun S, Bulavaite A, Sasnauskas K, Gerlich WH. 2005. Mapping of the hepatitis B virus attachment site by use of infectioninhibiting preS1 lipopeptides and tupaia hepatocytes. Gastroenterology 129: 234–245.
12. +-dependent taurocholate cotransporting polypeptide (NTCP). Eur J Pharm Sci 44: 487–496.
13. Gripon P, Diot C, Theze N, Fourel I, Loreal O, Brechot C, Guguen-Guillouzo C. 1988. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J Virol 62: 4136–4143.
14. Gripon P, Le Seyec J, Rumin S, Guguen-Guillouzo C. 1995. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology 213: 292–299.
15. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, Cannie I, Guyomard C, Lucas J, Trepo C, Guguen-Guillouzo C. 2002. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci 99: 15655–15660.
16. Gripon P, Cannie I, Urban S. 2005. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J Virol 79: 1613– 1622.
17. Guidotti LG, Matzke B, Schaller H, Chisari FV. 1995. Highlevel hepatitis B virus replication in transgenic mice. J Virol 69: 6158–6169.
18. +/bile acid cotransporter. J Clin Invest 93: 1326–1331.
19. +/bile acid cotransport system. Proc Natl Acad Sci 88: 10629–10633.
20. Hallen S, Bjorquist A, Ostlund-Lindqvist AM, Sachs G. 2002. Identification of a region of the ileal-type sodium/ bile acid cotransporter interacting with a competitive bile acid transport inhibitor. Biochemistry 41: 14916– 14924.
21. Hata S, Wang P, Eftychiou N, Ananthanarayanan M, Batta A, Salen G, Pang KS, Wolkoff AW. 2003. Substrate specificities of rat oatp1 and ntcp: Implications for hepatic or ganic anion uptake. Am J Physiol Gastrointest Liver Physiol 285: G829–G839.
22. Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH. 1984. Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol 52: 396–402.
23. Hilgendorf C, Ahlin G, Seithel A, Artursson P, Ungell AL, Karlsson J. 2007. Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab Dispos 35: 1333–1340.
24. Hong HJ, Ryu CJ, Hur H, Kim S, Oh HK, Oh MS, Park SY. 2004. In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees. Virology 318: 134–141.
25. Hu NJ, Iwata S, Cameron AD, Drew D. 2011. Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT. Nature 478: 408–411.
26. Huang HC, Chen CC, Chang WC, Tao MH, Huang C. 2012. Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis. J Virol 86: 9443–9453.
27. Iwamoto M, Watashi K, Tsukuda S, Aly HH, Fukasawa M, Fujimoto A, Suzuki R, Aizaki H, Ito T, Koiwai O, et al. 2014. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. Biochem Biophys Res Commun 443: 808–813.
28. Kock J, Nassal M, MacNelly S, Baumert TF, Blum HE, von Weizsacker F. 2001. Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J Virol 75: 5084–5089.
29. +/bile acid cotransporters of the rabbit: I. Transport studies with membrane vesicles and cell lines expressing the cloned transporters. J Lipid Res 40: 1604–1617.
30. Lamas Longarela O, Schmidt TT, Schoneweis K, Romeo R, Wedemeyer H, Urban S, Schulze A. 2013. Proteoglycans act as cellular hepatitis delta virus attachment receptors. PLoS ONE 8: e58340.
31. Leistner CM, Gruen-Bernhard S, Glebe D. 2008. Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cell Microbiol 10: 122–133.
32. Lempp FA, Urban S. 2014. Inhibitors of hepatitis B virus attachment and entry. Intervirology 57: 151–157.
33. Lempp FA, Ni Y, Lipps C, Wirth D, Urban S. 2014. Hepatitis B virus infection of mouse-human heterokaryonic cells indicates the absence of host-specific dependency factor(s) in mouse liver cell lines. In 2014 International Meeting on Molecular Biology of Hepatitis B Viruses, p. O-4. Los Angeles, CA.
34. Le Seyec J, Chouteau P, Cannie I, Guguen-Guillouzo C, Gripon P. 1998. Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity. J Virol 72: 5573–5578.
35. Le Seyec J, Chouteau P, Cannie I, Guguen-Guillouzo C, Gripon P. 1999. Infection process of the hepatitis B virus depends on the presence of a defined sequence in the preS1 domain. J Virol 73: 2052–2057.
36. Li H, Zhuang Q, Wang Y, Zhang T, Zhao J, Zhang Y, Zhang J, Lin Y, Yuan Q, Xia N, et al. 2014. HBV life cycle is restricted in mouse hepatocytes expressing human NTCP. Cell Mol Immunol 11: 175–183.
37. Macovei A, Radulescu C, Lazar C, Petrescu S, Durantel D, Dwek RA, Zitzmann N, Nichita NB. 2010. Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cells. J Virol 84: 243–253.
38. +-dependent bile acid transporter. Biochemistry 44: 13702–13712.
39. Meier A, Mehrle S, Weiss TS, Mier W, Urban S. 2013. Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes. Hepatology 58: 31–42.
40. Ni Y, Sonnabend J, Seitz S, Urban S. 2010. The pre-S2 domain of the hepatitis B virus is dispensable for infectivity but serves a spacer function for L-protein-connected virus assembly. J Virol 84: 3879–3888.
41. Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Falth M, Stindt J, Koniger C, Nassal M, Kubitz R, et al. 2014. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology 146: 1070–1083.
42. Patient R, Hourioux C, Roingeard P. 2009. Morphogenesis of hepatitis B virus and its subviral envelope particles. Cell Microbiol 11: 1561–1570.
43. Petersen J, Dandri M, Mier W, Lutgehetmann M, Volz T, von Weizsacker F, Haberkorn U, Fischer L, Pollok JM, Erbes B, et al. 2008. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat Biotechnol 26: 335–341.
44. Raney AK, Johnson JL, Palmer CN, McLachlan A. 1997. Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter. J Virol 71: 1058–1071.
45. ? Rizzetto M. 2015. HDV: Introduction and epidemiology. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a021576.
46. Salisse J, Sureau C. 2009. A function essential to viral entry underlies the hepatitis B virus “a” determinant. J Virol 83: 9321–9328.
47. Schieck A, Schulze A, Gahler C, Muller T, Haberkorn U, Alexandrov A, Urban S, Mier W. 2013. Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts. Hepatology 58: 43–53.
48. Schulze A, Gripon P, Urban S. 2007. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology 46: 1759–1768.
49. Sladek FM, Zhong WM, Lai E, Darnell JE Jr. 1990. Liverenriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 4: 2353–2365.
50. Stibbe W, Gerlich WH. 1983. Structural relationships between minor and major proteins of hepatitis B surface antigen. J Virol 46: 626–628.
51. Stieger B. 2011. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Handb Exp Pharmacol 201: 205–259.
52. Sun AQ, Balasubramaniyan N, Chen H, Shahid M, Suchy FJ. 2006. Identification of functionally relevant residues of the rat ileal apical sodium-dependent bile acid cotransporter. J Biol Chem 281: 16410–16418.
53. Sureau C, Salisse J. 2013. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus A-determinant. Hepatology 57: 985–994.
54. Tang H, McLachlan A. 2001. Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. Proc Natl Acad Sci 98: 1841–1846.
55. Taylor JM. 2013. Virus entry mediated by hepatitis B virus envelope proteins. World J Gastroenterol 19: 6730–6734.
56. Taylor JM. 2015. Hepatitis D virus replication. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a021568.
57. Trujillo MA, Letovsky J, Maguire HF, Lopez-Cabrera M, Siddiqui A. 1991. Functional analysis of a liver-specific enhancer of the hepatitis B virus. Proc Natl Acad Sci 88: 3797–3801.
58. Walter E, Keist R, Niederost B, Pult I, Blum HE. 1996. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 24: 1–5.
59. Watashi K, Iwamoto M, Sluder A, Matsunaga S, Ryo A, Morishita R, Kwon ATJ, Suzuki H, Tsukuda S, Suzuki R, et al. 2014a. Characterization of a culture system reproducing the NTCP-mediated HBVentry and its application to drug development. In 2014 International Meeting on Molecular Biology of Hepatitis B Viruses, p. O-7. Los Angeles, CA.
60. Watashi K, Sluder A, Daito T, Matsunaga S, Ryo A, Nagamori S, Iwamoto M, Nakajima S, Tsukuda S, BorrotoEsoda K, et al. 2014b. Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium tau rocholate cotransporting polypeptide (NTCP). Hepatology 59: 1726–1737.
61. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, et al. 2012. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 1: e00049.
62. Yan H, Peng B, He W, Zhong G, Qi Y, Ren B, Gao Z, Jing Z, Song M, Xu G, et al. 2013. Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide. J Virol 87: 7977–7991.
63. Yan H, Peng B, Liu Y, Xu G, He W, Ren B, Jing Z, Sui J, Li W. 2014. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide. J Virol 88: 3273–3284.
64. Yang D, Zuo C, Wang X, Meng X, Xue B, Liu N, Yu R, Qin Y, Gao Y, Wang Q, et al. 2014. Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line. Proc Natl Acad Sci 111: E1264–E1273.
65. Yanni SB, Augustijns PF, Benjamin DK Jr, Brouwer KL, Thakker DR, Annaert PP. 2010. In vitro investigation of the hepatobiliary disposition mechanisms of the antifungal agent micafungin in humans and rats. Drug Metab Dispos 38: 1848–1856.
66. Yu X, Mertz JE. 1997. Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily. J Virol 71: 9366–9374.
67. Zahner D, Eckhardt U, Petzinger E. 2003. Transport of taurocholate by mutants of negatively charged amino acids, cysteines, and threonines of the rat liver sodium-dependent taurocholate cotransporting polypeptide Ntcp. Eur J Biochem 270: 1117–1127.
68. Zhou X, Levin EJ, Pan Y, McCoy JG, Sharma R, Kloss B, Bruni R, Quick M, Zhou M. 2013. Structural basis of the alternating-access mechanism in a bile acid transporter. Nature 505: 569–573.